Notably, compared with patients without lymphoma, the percentages of FcRL4+ B cells are significantly increased in pSS patients with MALT-lymphomas, indicating that these B cells may contribute to the development of B cell lymphoma in pSS patients (21). This evidence concerns the gene FCRL4 and lymphoma.